CAMBRIDGE, Mass., Sept.*20, 2012 /PRNewswire/ --* Constellation Pharmaceuticals, Inc. , a leading biopharmaceutical company in the field of epigenetics, today announced that it has entered into a strategic ...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.